Stay updated on Low-Dose Cytarabine/Azacitidine+Venetoclax+Quizartinib in AML Clinical Trial

Sign up to get notified when there's something new on the Low-Dose Cytarabine/Azacitidine+Venetoclax+Quizartinib in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Low-Dose Cytarabine/Azacitidine+Venetoclax+Quizartinib in AML Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.3%
    Check dated 2025-01-19T19:43:08.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The website has updated the intervention type information to reflect a verified status by the PETHEMA Foundation as of September 2022, while also noting a revision from v2.13.3 to v2.14.0.
    Difference
    3%
    Check dated 2025-01-12T16:54:05.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    No Change Detected
  6. Check
    40 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.3%
    Check dated 2024-12-14T12:15:23.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.
    Difference
    0.3%
    Check dated 2024-12-07T10:18:05.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    The website has removed a detailed section regarding data download options and fields related to clinical study information.
    Difference
    13%
    Check dated 2024-11-23T03:54:22.000Z thumbnail image
  9. Check
    76 days ago
    Change Detected
    Summary
    The website has been updated to version v2.12.2, introducing new download options for data in various formats and a comprehensive selection of study fields, while the 'Recruiting' status has been removed from the previous version.
    Difference
    16%
    Check dated 2024-11-08T17:58:15.000Z thumbnail image

Stay in the know with updates to Low-Dose Cytarabine/Azacitidine+Venetoclax+Quizartinib in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Low-Dose Cytarabine/Azacitidine+Venetoclax+Quizartinib in AML Clinical Trial page.